Bausch Health signs LOI for PrOKEDI public coverage
The LOI covers PrOKEDI® 75mg and 100mg for adult schizophrenia, advancing public drug plan listing negotiations to secure nationwide patient access.
See the latest news and media coverage for Bausch Health. We track all announcements, press releases, and industry mentions in real time, all in one place.
Multinational pharmaceutical and healthcare products company
bauschhealth.comLast updated
In short: Bausch Health delivered strong 2026 first-quarter financial results while expanding its aesthetics presence in China and securing new FDA clearances.
The LOI covers PrOKEDI® 75mg and 100mg for adult schizophrenia, advancing public drug plan listing negotiations to secure nationwide patient access.
Revenues reach $2.52 billion, up 12%; Adjusted EPS $0.78, up 32%; reaffirms full-year guidance despite goodwill impairment.
Solta Medical, its aesthetics branch, introduces this laser approved by Health Canada on May 20, 2025 for customizable skin rejuvenation treatments.
Revenues reached $2.80B in Q4 (up 9%) and $10.27B for the year (up 7%). Adjusted EBITDA grew 13% in Q4. Acquired Shibo’s aesthetics business in China.
GAAP Net Loss Attributable to Bausch Health Companies of $58 million and GAAP Net Loss of $86 million. Consolidated Adjusted EBITDA Attributable to Bausch Health...
Bausch + Lomb (NYSE:BLCO) has launched Blink Triple Care Preservative Free eye drops in the U.S. The product targets consumers seeking gentler, longer-lasting relief from...
Bausch (BHC) earnings analysis | earnings surprises and market reaction remain in focus. Bausch Health Companies reported Q1 2026 earnings per share (EPS) of $0.78...
Capital Preservation- Join thousands of investors using our free market alerts, stock recommendations, and expert investment strategies to identify strong trading opportunities before major ...
Track Bausch Health and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Bausch Health and other trending companies.